Urispas and Metronidazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Urispas (flavoxate hydrochloride) and Metronidazole (metronidazole). Common drug interactions include metabolic acidosis among females.

The phase IV clinical study analyzes what interactions people have when they take Urispas and Metronidazole. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Urispas?

Urispas has active ingredients of flavoxate hydrochloride. eHealthMe is studying from 598 Urispas users. Check the latest studies of Urispas.

What is Metronidazole?

Metronidazole has active ingredients of metronidazole. It is often used in vaginitis bacterial. eHealthMe is studying from 59,578 Metronidazole users. Check the latest studies of Metronidazole.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

11 people who take Urispas and Metronidazole together, and have interactions are studied.

Urispas and Metronidazole drug interactions.

What are the common drug interactions of Urispas and Metronidazole, by gender? *:

female:

Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Oncologic complication
Confusional state
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Loss of consciousness
Weight decreased
Acute left ventricular failure (heart attack)

male:

n/a

What are the common drug interactions of Urispas and Metronidazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Oncologic complication

60+:

Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Loss of consciousness
Weight decreased
Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Altered state of consciousness (altered state of mind)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the existing conditions these people have? *

Postoperative Ileus: 3 people, 27.27%
Vitamin B12 Deficiency: 1 person, 9.09%
Fever: 1 person, 9.09%
Depression: 1 person, 9.09%
Diabetic Nephropathy (diabetic kidney disease): 1 person, 9.09%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 9.09%
Dizziness: 1 person, 9.09%
Drug Dependence: 1 person, 9.09%
Dry Skin: 1 person, 9.09%
Dysmenorrhea (painful menstruation): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Urispas and Metronidazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously